Evidence map›Paper›PMID 38886094›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2025

Kidney failure from kidney stones: an ANZDATA study.

Hicham Cheikh Hassan, David J Tunnicliffe, Lyn Loyd, Adam Mullan, Ieuan Wickham, Brydee Cashmore, Matthew Jose, Andrew J Mallett

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hicham Cheikh HassanGraduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.ORCID 0000-0002-9198-6092
David J TunnicliffeSydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Lyn LoydNutrition and Dietetics, Te Toka Tumai, Auckland, New Zealand.
Adam MullanNorthland Renal Services, Te Tai Tokerau, Northland, New Zealand.
Ieuan WickhamConsumer Partner, Kidney Stones Working Group, Caring for Australian and New Zealanders with Kidney Impairment.
Brydee CashmoreSydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Matthew JoseSchool of Medicine, University of Tasmania, Hobart, Tasmania, Australia.
Andrew J MallettDepartment of Renal Medicine, Townsville University Hospital, Douglas, Queensland, Australia.ORCID 0000-0002-8752-2551

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKidney stones are common, with an increasing trend over time, and have been well studied in the general population. However, the incidence and outcomes of kidney stones leading to kidney failure (KF) and the receipt of kidney replacement therapy (KRT) are poorly examined. We examined the incidence of KF due to kidney stones and compared outcomes with KRT patients due to other causes.

methodsWe studied adult patients who started KRT (January 1981-December 2020) and are included in the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry. Exposure was KRT patients due to kidney stones, comparing them with patients with other causes. We examined incidence, prevalence, patient survival (KRT and transplant) and graft survival (transplant). Cox regression models were fitted to compare patient survival between the kidney stones and non-kidney stones groups, overall KRT, dialysis and patient and graft survival after kidney transplant.

resultsA total of 834 (1.1%) patients commenced KRT due to kidney stones. The incidence was 1.17 per million population per year and remained stable during the study period (annual change -0.3% [95% confidence interval (CI) -1.5-0.9]. Survival was higher in kidney stone patients receiving dialysis compared with the non-kidney stone group [hazard ratio (HR) 0.89 (95% CI 0.82-0.96)], with similar estimates in a matched cohort. In kidney transplant patients, time to transplant was longer for patients with kidney stones compared with non-kidney stone patients (2.5 versus 1.7 years; P = .001). There was no difference in mortality [HR 1.02 (95% CI 0.82-1.28)] or graft loss [HR 1.07 (95% CI 0.79-1.45)] between the kidney stones and non-kidney stones patients in the kidney transplant group.

conclusionThe incidence of KF due to kidney stones was unchanged over the study period. Survival of patients with kidney stones who require KRT was better compared with patients with other causes. For the kidney transplant group, survival and risk of graft failure were similar.

Indexed as

Kidney CalculiKidney Failure, ChronicRegistriesRenal DialysisRenal InsufficiencyRenal Replacement TherapyAdultAgedAustraliaFemaleFollow-Up StudiesGraft SurvivalHumansIncidenceKidney TransplantationMaleANZDATAdialysiskidney stonesmortalitytransplantation

Identifiers

PMID38886094
PMCPMC11792657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.